RNAi News GenomeWeb News Premium Content Existing subscribers login here. New to RNAi News? For a trial subscription click here.

MicroRNA Drugs Startup Miragen Nears
Close of Series A, Begins Defining Pipeline

[May 15, 2008]

By Doug Macron

While specific details of Miragen’s planned pipeline are being kept under wraps, a company official said that the initial indication pursued would likely be heart failure, a condition one of the firm’s co-founders has linked to several microRNAs.

Login | Subscribe